PECAM1 and neoplasm: CD31 immunostaining and quantification of vascular hotspots demonstrated an 82% reduction in neovascularization following intratumoral injection and a 94% reduction following intravenous administration of liposomal contortrostatin, highlighting the therapeutic potential of venom-derived peptides in targeting tumor vasculature.